Welcome to our dedicated page for Definitive Healthcare news (Ticker: DH), a resource for investors and traders seeking the latest updates and insights on Definitive Healthcare stock.
Definitive Healthcare Corp. reports developments in healthcare market data, analytics, and commercial intelligence for organizations operating on the business side of healthcare. Its SaaS-based platform and related solutions support use cases such as market selection, go-to-market planning, provider targeting, affiliation analysis, prescription-pattern visibility, Key Opinion Leader identification, and workflow data enrichment.
Recurring news for DH includes quarterly and annual financial results, guidance commentary, customer wins and renewals across life sciences and health-system markets, expansions involving products such as Monocl and Population Intelligence, data-integration use cases, and investor conference presentations. Company updates also describe subscription revenue trends, adjusted profitability measures, cash flow, and commercial execution across new logos and existing customers.
Definitive Healthcare (Nasdaq: DH) reported second quarter 2026 revenue of $55.2 million, down 9% from $60.8 million a year earlier but within its guidance range. Net loss improved to $(7.5) million (14% margin) versus $(9.3) million (15% margin) in Q2 2025.
Adjusted EBITDA was $14.6 million, or 26% of revenue, compared with $18.7 million and a 31% margin a year ago. Cash flow from operations reached $11.5 million, and unlevered free cash flow was $11.6 million. The company highlighted win-back and expansion deals and launched Turbo, an AI-powered healthcare intelligence platform.
For full-year 2026, Definitive Healthcare expects revenue of $220–$222 million, adjusted EBITDA of $57–$59 million (26–27% margin), and adjusted net income of $27–$29 million.
Definitive Healthcare (Nasdaq: DH) has launched an early adopter program for a new AI-powered healthcare intelligence platform, offering select organizations early access ahead of planned general availability in late 2026.
The platform combines Definitive Healthcare’s data assets with conversational AI to unify claims, provider, consumer, affiliation, and KOL datasets. It is designed to help users size market opportunities, optimize sales territories, prioritize high-value prospects, find decision makers, and reduce patient leakage. Early adopter customers across health systems, life sciences, and other healthcare-focused industries will begin participating in August 2026, providing feedback to refine the final product.
Definitive Healthcare (Nasdaq: DH) will report financial results for its second quarter ended June 30, 2026 on Monday, August 10, 2026, after market close. The company will host a conference call and webcast at 5:00 PM ET / 2:00 PM PT, with live access via its Investor Relations website, domestic and international dial-ins, and a replay available through September 9, 2026 using passcode 1765#.
Definitive Healthcare (Nasdaq: DH) disclosed that its Human Capital Management and Compensation Committee granted inducement equity awards in connection with hiring a new senior leader, in line with Nasdaq Listing Rule 5635(c)(4). The company granted 1,063,830 time-based RSUs to Srinivas Attipalli, its new SVP and Head of AI & Data - Product, effective July 24, 2026.
According to Definitive Healthcare, the award was individually negotiated, made under the company’s 2023 Inducement Plan, and is subject to an applicable award agreement. The RSUs vest 25% on June 1, 2027, with the remaining 75% vesting in equal quarterly installments of 6.25% until fully vested, contingent on continued employment.
Restaurant365 appointed Kate Hastings as Chief Customer Officer to lead all post-sale customer functions, including success, support, onboarding, implementation, and professional services. With 15+ years of experience and prior CCO role at Definitive Healthcare (Nasdaq: DH), she will focus on driving measurable outcomes for restaurant operators amid rising costs and complexity.
Hastings will also appear at Transform 2026, Restaurant365's customer conference, November 1–3 in Scottsdale, Arizona.
Definitive Healthcare (Nasdaq: DH) announced product enhancements to strengthen its healthcare data platform and integrations. Updates include expanded Atlas All-Payor Claims coverage, a new HubSpot CRM integration, direct access to affiliated HCP data in Salesforce via DefinitiveConnect, and new AI search in Monocl ExpertInsight and the View Suite.
These enhancements aim to give organizations a more complete, connected view of the healthcare ecosystem and make insights easier to use across sales, marketing, strategy, medical affairs, and product development.
Definitive Healthcare (Nasdaq: DH) reported Q1 2026 results for the quarter ended March 31, 2026. Revenue was $55.9 million (down 6% YoY). Net loss was $(192.4) million, inclusive of $197.2 million goodwill impairment. Adjusted net income was $8.5 million; Adjusted EBITDA was $15.3 million (27% of revenue). Cash flow from operations was $11.6 million and unlevered free cash flow was $18.0 million. Q2 2026 and full‑year 2026 guidance ranges were provided, including full‑year revenue $220.0–$226.0 million.
Definitive Healthcare (Nasdaq: DH) will report Q1 2026 financial results for the quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM ET / 2:00 PM PT.
Live audio webcast access is available on the company’s Investor Relations website. Domestic and international dial-in numbers are provided, and a replay will be available through June 6, 2026 with passcode 1765#.
Definitive Healthcare (Nasdaq: DH) reported fourth quarter and full year 2025 results on Feb 26, 2026. Q4 revenue was $61.5M; full-year revenue was $241.5M. Adjusted EBITDA was $18.0M (29% of revenue) in Q4 and $70.4M (29% margin) for the year. Cash flow from operations was $53.8M for 2025 and unlevered free cash flow was $54.9M. The company recorded significant goodwill impairments ($196.1M full year) and reported adjusted net income of $34.9M for 2025. Guidance for 2026 projects revenue of $220.0–$226.0M and adjusted EBITDA of $53.0–$58.0M.
Definitive Healthcare (Nasdaq: DH) will report fourth quarter and full year 2025 results on Thursday, February 26, 2026 after market close. The company will host a conference call and webcast at 5:00 PM ET / 2:00 PM PT to discuss results.
Live audio webcast will be available on the company’s Investor Relations website. Domestic dial-in is 877-358-7298; international dial-in is +1-848-488-9244. A replay will be available through March 26, 2026 with passcode 1765#.